Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome-brain-cirrhosis axis
Maren L. Smith, James B. Wade, Jennifer T. Wolstenholme, et al.
Hepatology (2023) Vol. 80, Iss. 2, pp. 465-485
Closed Access | Times Cited: 20

Showing 20 citing articles:

Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms
Jiao Wang, Jiayi Lin, Yanfang Deng, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
Laure Elkrief, Virginia Hernández–Gea, Marco Senzolo, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 9, pp. 859-883
Closed Access | Times Cited: 13
Depression-like phenotypes in mice following common bile duct ligation: Insights into the gut–liver–brain axis via the vagus nerve
Yong Yang, Akifumi Eguchi, Chisato Mori, et al.
Neurobiology of Disease (2024) Vol. 192, pp. 106433-106433
Open Access | Times Cited: 9
The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy
Jasmohan S. Bajaj, Andrew Fagan, Edith Gavis, et al.
Hepatology Communications (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 7
New insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease
Luis Antonio Díaz, Gerald Scott Winder, Lorenzo Leggio, et al.
Hepatology (2023)
Closed Access | Times Cited: 15
Recent Insights on the Role of Nuclear Receptors in Alzheimer’s Disease: Mechanisms and Therapeutic Application
Xiaoxiao Shan, Dawei Li, Huihui Yin, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1207-1207
Open Access
Gut Microbiome-Liver-Brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches.
Emilio Merlo Pich, Ioannis Tarnanas, Patrizia Brigidi, et al.
Neurobiology of Stress (2025), pp. 100713-100713
Open Access
Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer's disease mice: Potential role in chronic heavy alcohol feeding
Devaraj V. Chandrashekar, G. Chuli Roules, Nataraj Jagadeesan, et al.
Neurobiology of Disease (2024) Vol. 199, pp. 106570-106570
Open Access | Times Cited: 4
Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications
Siyou Tan, Wenyan Chen, Gaoyin Kong, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 10
Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis
Thananya Jinato, Masoumeh Sikaroodi, Andrew Fagan, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 8
Viral Liver Disease and Intestinal Gut–Liver Axis
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Gastrointestinal Disorders (2024) Vol. 6, Iss. 1, pp. 64-93
Open Access | Times Cited: 2
Microbiota-gut-liver-brain axis and hepatic encephalopathy
Haifeng Lu, Hua Zhang, Zhongwen Wu, et al.
Microbiome Research Reports (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 2
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice
Paula M. Chilton, Smita Ghare, B Charpentier, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
A specialized HE testing clinic improves rational decision-making for therapy in cirrhosis
Mahum Nadeem, Asiya Tafader, Dan Park, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 5
Gut Bacteria in Alcohol-Associated Liver Disease
Yongqiang Yang, Bernd Schnabl
Clinics in Liver Disease (2024) Vol. 28, Iss. 4, pp. 663-679
Closed Access | Times Cited: 1
PAMK Ameliorates Non-Alcoholic Steatohepatitis and Associated Anxiety/Depression-like Behaviors Through Restoring Gut Microbiota and Metabolites in Mice
Jianmei Yang, Wanyi Ou, Guiru Lin, et al.
Nutrients (2024) Vol. 16, Iss. 22, pp. 3837-3837
Open Access | Times Cited: 1
The Potential of Edible and Medicinal Resource Polysaccharides for Prevention and Treatment of Neurodegenerative Diseases
Qingxia Gan, Yugang Ding, Maoyao Peng, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 873-873
Open Access | Times Cited: 3
Therapeutic manipulation of the microbiome in liver disease
Gopanandan Parthasarathy, Harmeet Malhi, Jasmohan S. Bajaj
Hepatology (2024)
Closed Access
Keratin 18‐M65: A biomarker for early‐stage alcohol‐associated liver disease
Craig J. McClain, Irina Kirpich, Ming Song, et al.
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 7, pp. 1257-1260
Open Access
Page 1

Scroll to top